EFFICACY AND SAFETY OF SEQUENTIAL DIFFERENT B CELL ANTIGEN-TARGETED CAR T-CELL THERAPY FOR PEDIATRIC REFRACTORY/RELAPSED BURKITT LYMPHOMAWITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT

被引：0
|
作者：
Liu, Y. [1 ]
Deng, B. [2 ]
Hu, B. [1 ]
Zhang, W. [1 ]
Zhu, Q. [1 ]
Liu, Y. [1 ]
Wang, S. [1 ]
Zhang, P. [1 ]
Yang, J. [1 ]
Zheng, Q. [3 ]
Yu, X. [3 ]
Gao, Z. [4 ]
Zhou, C. [5 ]
Han, W. [6 ]
Chang, A. [7 ]
Zhang, Y. [1 ]
机构：
[1] Beijing Boren Hosp, Dept Pediat Lymphoma, Beijing, Peoples R China
[2] Beijing Boren Hosp, Cytol Lab, Beijing, Peoples R China
[3] Beijing Boren Hosp, Med Lab, Beijing, Peoples R China
[4] Peking Univ Third Hosp, Dept Pathol, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Natl Ctr Childrens Hlth, Beijing, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Dept Epidemiol & Biostat, Inst Basic Med Sci, Sch Basic Med, Beijing, Peoples R China
[7] Tongji Univ, Sch Med, Clin Translat Res Ctr, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
046
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [41] Clinical updates of B-cell maturation antigen-targeted therapy in multiple myeloma (MM) and relapsed/refractory MM (Review)
    Xing, Rui
    Wang, Meidan
    Wang, Liqun
    Pan, Mingyue
    Wang, Yixi
    Zhou, Hongwei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (02)
  • [42] Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma.
    Zhao, Liping
    Pan, Jing
    Tang, Kaiting
    Tan, Yue
    Deng, Biping
    Ling, Zhuojun
    Song, Weiliang
    Chang, Alex H.
    Feng, Xiaoming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Efficacy and safety of CAR19/22 T-cell "cocktail" therapy in patients with refractory/relapsed B-cell non-Hodgkin lymphoma.
    Huang, Liang
    Wang, Na
    Li, Chunrui
    Xiao, Yi
    Cao, Yang
    Xiao, Min
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer
    Hoyos, Valentina
    Vasileiou, Spyridoula
    Kuvalekar, Manik
    Watanabe, Ayumi
    Tzannou, Ifigeneia
    Velazquez, Yovana
    French-Kim, Matthew
    Leung, Wingchi
    Lulla, Suhasini
    Robertson, Catherine
    Foreman, Claudette
    Wang, Tao
    Bulsara, Shaun
    Lapteva, Natalia
    Grilley, Bambi
    Ellis, Matthew
    Osborne, Charles Kent
    Coscio, Angela
    Nangia, Julie
    Heslop, Helen E.
    Rooney, Cliona M.
    Vera, Juan F.
    Lulla, Premal
    Rimawi, Mothaffar
    Leen, Ann M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [45] Efficacy and Safety of CD19-Targeted CAR-T Cell Therapy for Refractory/Relapsed B-Cell Lymphoma: A Single Center of Real World Data
    Huang, Jing
    Fei, Jia
    Ou, Ruiming
    Liu, Zhi
    Zheng, Liling
    Zhu, Yangmin
    Shen, Huijuan
    Du, Yuanyuan
    Zhou, Qinjun
    Chen, Jiali
    Zhou, Changhua
    Yan, Rongrong
    Wang, Jiale
    Liu, Shuang
    Zhang, Qing
    BLOOD, 2021, 138
  • [46] Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review
    Liu, Yifan
    Li, Yanfen
    Yu, Zhangyu
    Wang, Rongrong
    Jing, Yu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [48] The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL
    Forsberg, Matthew H.
    Das, Amritava
    Saha, Krishanu
    Capitini, Christian M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1573 - 1584
  • [49] Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia
    Liu, Sining
    Cui, Qingya
    Li, Zheng
    Cui, Wei
    Li, Mengyun
    Qiu, Huiying
    Xue, Shengli
    Chen, Suning
    Jin, Zhengming
    Miao, Miao
    Han, Yue
    Wang, Ying
    Zhu, Xiaming
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2023, 142
  • [50] EFFICACY AND TOXICITY FOR CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMA
    Su, Guoai
    Yang, Fan
    Shi, Hui
    Liu, Rui
    Li, Ruiting
    Xu, Teng
    Feng, Shaoma
    Zheng, Peihao
    Guo, Yuelu
    Ma, Lixia
    Deng, Biping
    Ke, Xiaoyan
    Hu, Kai
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 196 - 197
12345